Particulars |
Company Name |
Glaxosmithkline Pharmaceuticals Ltd |
Year End |
202403 |
Full Year |
Equity (Rs Cr.) |
169.41 |
B.V. Rs |
105.30 |
Sales Rs Cr. |
3,407.25 |
NP Rs Cr. |
686.46 |
NP Var% |
17.00 |
Div% |
320.00 |
CPS Rs |
44.60 |
EPS Rs |
40.50 |
Traded Value(Rs Lakhs) |
273.65 |
52 Week High |
2,650.00 |
52 Week Low |
1,275.00 |
Price BSE |
2,344.00 |
Price NSE |
2,344.00 |
Market Capital(Rs Cr.) |
39,716.40 |
P/C Ratio |
52.50 |
P/E Ratio |
57.80 |
Price Vs.BV |
22.26 |
|
Latest Quarter |
Year End |
202403 |
Sales Rs Cr. |
910.87 |
NP Rs Cr. |
191.36 |
NP Var % |
54.00 |
Trailing Twelve Months |
Year End |
202403 |
Sales |
3,234.97 |
OPM |
27.84 |
NP |
412.71 |
NP Var% |
17.00 |
EPS |
40.52 |
PE |
57.86 |
|
|